Cancer BiologybioRxivPreprint
Targeting MDSC-HTR2B to Improve Immune Checkpoint Inhibitors in Breast to Brain Metastasis
Mukund Iyer, Diganta Das, Aaron G. Baugh…·Josh Neman
The paper identifies HTR2B on MDSCs as a target to enhance immune checkpoint inhibitors in breast-to-brain metastasis using clozapine and anti-PD-1 therapy.
DOI 10.1101/2024.06.20.599939